Abstract

Cytochrome P450 (P450) 3A4, the major catalyst involved in human drug oxidation, displays substrate- and reaction-dependent homotropic and heterotropic cooperative behavior. Although several models have been proposed, these mainly rely on steady-state kinetics and do not provide information on the contribution of the individual steps of P450 catalytic cycle to the observed cooperativity. In this work, we focused on the kinetics of substrate binding, and the fluorescent properties of bromocriptine and alpha-naphthoflavone allowed analysis of an initial ligand-P450 3A4 interaction that does not cause a perturbation of the heme spectrum. The binding stoichiometry for bromocriptine was determined to be unity using isothermal titration calorimetry and equilibrium dialysis methods, suggesting that the ligand bound to the peripheral site during the initial encounter dissociates subsequently. A three-step substrate binding model is proposed, based on absorbance and fluorescence stopped-flow kinetic data and equilibrium binding data obtained with bromocriptine, and evaluated using kinetic modeling. The results are consistent with the substrate molecule binding at a site peripheral to the active site and subsequently moving toward the active site to bind to the heme and resulting in a low to high spin iron shift. The last step is attributed to a conformational change in the enzyme active site. The later steps of binding were shown to have rate constants comparable with the subsequent steps of the catalytic cycle. The P450 3A4 binding process is more complex than a two-state system, and the overlap of rates of some of the events with subsequent steps is proposed to underlie the observed cooperativity.

Highlights

  • P450 3A4 is one of the most widely studied of the 57 human P450s [5], mainly due to its role in the metabolism of more than one-half of the drugs on the market as well as various endogenous and exogenous molecules [6, 7]

  • We have examined the relevance of the individual steps of ligand binding to reduction of ferric to ferrous P450 subsequent event in the catalytic cycle of P450 3A4

  • The focus of this study was the kinetics of ligand binding with P450 3A4

Read more

Summary

EXPERIMENTAL PROCEDURES

Chemicals—␣-Naphthoflavone, midazolam, flavone, and bromocriptine were purchased from Sigma. Kinetic traces were extracted from the acquired spectra, utilizing either ⌬A390 or ⌬A390 Ϫ A418 (or ⌬A390 Ϫ A420) and were analyzed using the manufacturer’s software (OLIS), GraphPad Prism, or DynaFit. Binding kinetics of testosterone and bromocriptine to P450 3A4 were measured using the reconstituted system. Binding kinetics of testosterone and bromocriptine to P450 3A4 were measured using the reconstituted system In these experiments, one of the drive syringes contained P450 3A4 (2 ␮M), NADPH-P450 reductase (4 ␮M), cytochrome b5 (2 ␮M), and other components of the reconstitution system. After mixing the contents of the drive syringes, emission spectra were collected as a function of time with a midplane photomultiplier tube and using the 16 ϫ 1-mm scan disk.

Ks analysis kab kbb Testosterone Midazolam Bromocriptine Flavone
Apparent second order k rate constant
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.